Sams M A Sadat

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 4

Top Topics

Particulate Matter

Magnetic Resonance Imaging

Top Venues

Molecular pharmaceutics

University of Alberta (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

University of Alberta Jan 01 2017

Canada

PHD :: Faculty of Pharmacy & Pharmaceuticals Sciences

University of Saskatchewan Sep 01 2015 - Dec 31 2016

Canada

PHD :: Microbiology & Immunology

University of Saskatchewan Sep 01 2012 - Aug 31 2015

Canada

MSC :: College of Pharmacy & Nutrition

University of Dhaka Sep 01 2007 - Aug 31 2009

Bangladesh

MSC :: Faculty of Pharmacy (Pharmaceutical Technology)

University of Dhaka May 01 2002 - Aug 31 2007

Bangladesh

BSC :: Faculty of Pharmacy

Publications

Sams M A Sadat, Mohammad Reza Vakili, Sara I Abd-El Hafeez, Marco Paladino, Dennis G Hall, Michael Weinfeld, Afsaneh Lavasanifar
Synergistic Nanomedicine Delivering Topoisomerase I Toxin (SN-38) and Inhibitors of Polynucleotide Kinase 3'-Phosphatase (PNKP) for Enhanced Treatment of Colorectal Cancer. Molecular pharmaceutics (2024)
Sams M A Sadat, Mohammad Reza Vakili, Sara I Abd-El Hafeez, Marco Paladino, Dennis G Hall, Michael Weinfeld, Afsaneh Lavasanifar
Synergistic Nanomedicine Delivering Topoisomerase I Toxin (SN-38) and Inhibitors of Polynucleotide Kinase 3'-Phosphatase (PNKP) for Enhanced Treatment of Colorectal Cancer. Molecular pharmaceutics 21 (7) (2024)
Sams M A Sadat, Mohammad Reza Vakili, Sara I Abd-El Hafeez, Marco Paladino, Dennis G Hall, Michael Weinfeld, Afsaneh Lavasanifar
Synergistic Nanomedicine Delivering Topoisomerase I Toxin (SN-38) and Inhibitors of Polynucleotide Kinase 3'-Phosphatase (PNKP) for Enhanced Treatment of Colorectal Cancer. Molecular pharmaceutics 21 (7) (2024)
Sams M A Sadat, Mohammad Reza Vakili, Igor Moura de Paiva, Michael Weinfeld, Afsaneh Lavasanifar
Development of Self-Associating SN-38-Conjugated Poly(ethylene oxide)-Poly(ester) Micelles for Colorectal Cancer Therapy. Pharmaceutics 12 (11) (2020)